Ren S - Search Results

1

A Consideration of Fixed Dosing Versus Body Size-Based Dosing Strategies for Chimeric Antigen Receptor T-Cell Therapies.

He JZ, Wang H, Lim K, Ren S, Rollins F, Vallaster M, Wong R, Stebbings R, Standifer N, Keefe R, Phipps A, Gibbs M. He JZ, et al. Among authors: ren s. Clin Pharmacol Drug Dev. 2022 Oct;11(10):1130-1135. doi: 10.1002/cpdd.1171. Epub 2022 Sep 12. Clin Pharmacol Drug Dev. 2022. PMID: 36094760 Free PMC article. No abstract available.

2

Pharmacokinetic Interaction Study Between Saxagliptin and Omeprazole, Famotidine, or Magnesium and Aluminum Hydroxides Plus Simethicone in Healthy Subjects: An Open-Label Randomized Crossover Study.

Ren S, Boulton DW. Ren S, et al. Clin Pharmacol Drug Dev. 2019 May;8(4):549-558. doi: 10.1002/cpdd.634. Epub 2018 Nov 30. Clin Pharmacol Drug Dev. 2019. PMID: 30500110 Clinical Trial.

3

Pharmacokinetics and pharmacodynamics of MEDI0680, a fully human anti-PD-1 monoclonal antibody, in patients with advanced malignancies.

Song X, Khan AA, Zhou D, Elgeioushi N, Walcott F, Ren S, Gibbs M. Song X, et al. Among authors: ren s. Cancer Chemother Pharmacol. 2022 Mar;89(3):373-382. doi: 10.1007/s00280-022-04396-5. Epub 2022 Feb 8. Cancer Chemother Pharmacol. 2022. PMID: 35133489

4

Population Pharmacokinetics of Monalizumab in Patients With Advanced Solid Tumors.

Hwang M, Fan C, Yue MS, Zhou D, Paturel C, Andre P, Cheng LY, Mitchell P, Kourtesis P, Ruscica D, Das M, Morsli N, Ren S, Gibbs M, Phipps A, Song X. Hwang M, et al. Among authors: ren s. J Clin Pharmacol. 2023 Jul;63(7):817-829. doi: 10.1002/jcph.2220. Epub 2023 Apr 10. J Clin Pharmacol. 2023. PMID: 36852723

5

Clinical Pharmacology Strategies for Bispecific Antibody Development: Learnings from FDA-Approved Bispecific Antibodies in Oncology.

Lim K, Zhu XS, Zhou D, Ren S, Phipps A. Lim K, et al. Among authors: ren s. Clin Pharmacol Ther. 2024 Aug;116(2):315-327. doi: 10.1002/cpt.3308. Epub 2024 Jun 2. Clin Pharmacol Ther. 2024. PMID: 38825990 Review.

6

A Phase 1, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Subcutaneous Tezepelumab in Healthy Japanese Men.

Sakamoto K, Matsuki S, Irie S, Uchida N, Hayashi N, Horiuchi M, Ren S. Sakamoto K, et al. Among authors: ren s. Clin Pharmacol Drug Dev. 2020 Oct;9(7):833-840. doi: 10.1002/cpdd.775. Epub 2020 Jan 20. Clin Pharmacol Drug Dev. 2020. PMID: 31960624 Free PMC article. Clinical Trial.

7

Clinical evaluation of the potential drug-drug interactions of savolitinib: Interaction with rifampicin, itraconazole, famotidine or midazolam.

Ren S, Vishwanathan K, Cantarini M, Frewer P, Hara I, Scarfe G, Burke W, Schalkwijk S, Li Y, Han D, Goldwater R. Ren S, et al. Br J Clin Pharmacol. 2022 Feb;88(2):655-668. doi: 10.1111/bcp.14994. Epub 2021 Aug 21. Br J Clin Pharmacol. 2022. PMID: 34322894 Free PMC article.

8

Evolving drug regulatory landscape in China: A clinical pharmacology perspective.

Tang W, Huang Y, Zhou D, Huang Y, Chen Y, Ren S, Li Y, Wu S, Zhao X, Song X, Wang H, Jin Y, Yu H, Zhang L, Li Y, Boulton D, Shen K. Tang W, et al. Among authors: ren s. Clin Transl Sci. 2021 Jul;14(4):1222-1230. doi: 10.1111/cts.12987. Epub 2021 Feb 23. Clin Transl Sci. 2021. PMID: 33503308 Free PMC article. Review.

9

Developability profiling of a panel of Fc engineered SARS-CoV-2 neutralizing antibodies.

Dippel A, Gallegos A, Aleti V, Barnes A, Chen X, Christian E, Delmar J, Du Q, Esfandiary R, Farmer E, Garcia A, Li Q, Lin J, Liu W, Machiesky L, Mody N, Parupudi A, Prophet M, Rickert K, Rosenthal K, Ren S, Shandilya H, Varkey R, Wons K, Wu Y, Loo YM, Esser MT, Kallewaard NL, Rajan S, Damschroder M, Xu W, Kaplan G. Dippel A, et al. Among authors: ren s. MAbs. 2023 Jan-Dec;15(1):2152526. doi: 10.1080/19420862.2022.2152526. MAbs. 2023. PMID: 36476037 Free PMC article.

10

Osimertinib Plus Durvalumab in Patients With EGFR-Mutated, Advanced NSCLC: A Phase 1b, Open-Label, Multicenter Trial.

Ahn MJ, Cho BC, Ou X, Walding A, Dymond AW, Ren S, Cantarini M, Jänne PA. Ahn MJ, et al. Among authors: ren s. J Thorac Oncol. 2022 May;17(5):718-723. doi: 10.1016/j.jtho.2022.01.012. Epub 2022 Feb 15. J Thorac Oncol. 2022. PMID: 35181499 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,131 results

Search Page

Filters